Non-small-cell Lung Cancer (NSCLC) Clinical Trial
Official title:
A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer
Objectives:
1. Primary Objective:
To bridge the data of efficacy in term of overall response rate of TS-1 plus cisplatin
in Taiwanese advanced NSCLC patients from that gained from Japanese population
2. Secondary Objectives:
A. To assess progression free survival B. To assess overall survival C. To bridge the safety
profile by assessing the toxicities and tolerability
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03725475 -
A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients
|
||
| Recruiting |
NCT06357598 -
Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer
|
Phase 4 | |
| Recruiting |
NCT02448992 -
Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer
|
Phase 2/Phase 3 | |
| Completed |
NCT02113813 -
A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations
|
Phase 1 | |
| Active, not recruiting |
NCT04338620 -
Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC
|
Phase 2 | |
| Completed |
NCT06232967 -
PPIO-006 Primary Tumor Resection for IVa NSCLC
|